JPWO2020178742A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020178742A5
JPWO2020178742A5 JP2021552604A JP2021552604A JPWO2020178742A5 JP WO2020178742 A5 JPWO2020178742 A5 JP WO2020178742A5 JP 2021552604 A JP2021552604 A JP 2021552604A JP 2021552604 A JP2021552604 A JP 2021552604A JP WO2020178742 A5 JPWO2020178742 A5 JP WO2020178742A5
Authority
JP
Japan
Prior art keywords
tcr
amino acid
hla
seq
constant region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021552604A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022524993A (ja
JP2022524993A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2020/051811 external-priority patent/WO2020178742A1/en
Publication of JP2022524993A publication Critical patent/JP2022524993A/ja
Publication of JPWO2020178742A5 publication Critical patent/JPWO2020178742A5/ja
Publication of JP2022524993A5 publication Critical patent/JP2022524993A5/ja
Priority to JP2025011527A priority Critical patent/JP7825752B2/ja
Withdrawn legal-status Critical Current

Links

JP2021552604A 2019-03-04 2020-03-03 Ｔ細胞受容体及びその使用方法 Withdrawn JP2022524993A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025011527A JP7825752B2 (ja) 2019-03-04 2025-01-27 Ｔ細胞受容体及びその使用方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962813647P 2019-03-04 2019-03-04
US62/813,647 2019-03-04
PCT/IB2020/051811 WO2020178742A1 (en) 2019-03-04 2020-03-03 T cell receptors and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025011527A Division JP7825752B2 (ja) 2019-03-04 2025-01-27 Ｔ細胞受容体及びその使用方法

Publications (3)

Publication Number Publication Date
JP2022524993A JP2022524993A (ja) 2022-05-11
JPWO2020178742A5 true JPWO2020178742A5 (https=) 2023-03-13
JP2022524993A5 JP2022524993A5 (https=) 2023-03-13

Family

ID=72337382

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021552604A Withdrawn JP2022524993A (ja) 2019-03-04 2020-03-03 Ｔ細胞受容体及びその使用方法
JP2025011527A Active JP7825752B2 (ja) 2019-03-04 2025-01-27 Ｔ細胞受容体及びその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025011527A Active JP7825752B2 (ja) 2019-03-04 2025-01-27 Ｔ細胞受容体及びその使用方法

Country Status (13)

Country Link
US (1) US20220152105A1 (https=)
EP (1) EP3935177A4 (https=)
JP (2) JP2022524993A (https=)
KR (1) KR20210144740A (https=)
CN (1) CN113795585B (https=)
AU (1) AU2020231107A1 (https=)
BR (1) BR112021017467A2 (https=)
CA (1) CA3132434A1 (https=)
IL (1) IL286041A (https=)
MX (1) MX2021010539A (https=)
SG (1) SG11202109593SA (https=)
TW (1) TWI877144B (https=)
WO (1) WO2020178742A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE058957T2 (hu) 2016-12-08 2022-10-28 Immatics Biotechnologies Gmbh Új T-sejt receptorok és velük végzett immunterápia
JP7748284B2 (ja) 2019-03-04 2025-10-02 ユニバーシティー ヘルス ネットワーク Ｔ細胞受容体及びその使用方法
MX2021010541A (es) 2019-03-04 2021-12-15 Univ Health Network Receptores de linfocitos t y metodos de uso de estos.
CN113795586B (zh) 2019-03-25 2026-03-27 大学健康网络 T细胞受体及其使用方法
CN112239495B (zh) * 2020-10-29 2022-04-12 上海药明生物技术有限公司 稳定的tcr结构及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008206442B2 (en) * 2007-01-12 2012-10-18 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services gp100-specific T cell receptors and related materials and methods of use
US9051391B2 (en) * 2007-06-11 2015-06-09 Takara Bio Inc. Method for expression of specific gene
WO2010037395A2 (en) * 2008-10-01 2010-04-08 Dako Denmark A/S Mhc multimers in cancer vaccines and immune monitoring
US11396536B2 (en) * 2016-04-27 2022-07-26 University Health Network Peptide-HLA complexes and methods of producing same

Similar Documents

Publication Publication Date Title
JP2022109953A5 (https=)
JP2022169543A (ja) 改善された養子ｔ細胞療法
Shilyansky et al. T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines.
Spear et al. Strategies to genetically engineer T cells for cancer immunotherapy
CN109694854B (zh) 通用型嵌合抗原受体t细胞制备技术
US11052138B2 (en) Use of car and bite technology coupled with an SCFV from an antibody against human thymidine kinase 1 to specifically target tumors
JP2020509767A5 (https=)
CN112088008A (zh) 修饰细胞的扩增及其用途
JP2019519245A5 (https=)
Tsang et al. Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen.
JP2023534808A (ja) 養子細胞療法のための標的共刺激を提供する受容体
CN113423726A (zh) 为过继细胞治疗提供靶向共刺激的受体
JPWO2019173324A5 (https=)
WO2017070649A1 (en) Combination methods for immunotherapy
CN114616337A (zh) 嵌合CD3融合蛋白与基于anti-CD3的双特异性T细胞激活元件的联合表达
JP2020533962A5 (https=)
JPWO2020194195A5 (https=)
JPWO2020048995A5 (https=)
JPWO2020178739A5 (https=)
JPWO2020178742A5 (https=)
JPWO2020178738A5 (https=)
CN113785064B (zh) T细胞受体及其使用方法
JPWO2020178741A5 (https=)
JPWO2020178740A5 (https=)
JPWO2020178743A5 (https=)